GW28-e0867 Health-Related Quality of Life in Blood Pressure Control and Blood Lipid Lowering Therapies: Results from the CHIEF Randomized Controlled Trial

Objectives To explore the changes in health-related quality of life (HRQoL) during blood pressure control and blood lipid lowering therapies, and to investigate the variations in HRQoL between different interventions or between different blood pressure/lipid levels. At baseline, participants were randomly assigned to amlodipine + compound amiloride group or amlodipine + telmisartan group for blood pressure control treatment, and to statin group or routine intervention group for blood lipid lowering treatment.